Table 1 Patient population and known clinical parameters
Patient demographics | n=32 |
|---|---|
Age (years) | Median = 64. 5 (44–76) |
Sex | |
Male | 29 (91%) |
Female | 3 (9%) |
Race | |
White | 30 (94%) |
Black | 1 (3%) |
Hispanic | 1 (3%) |
Tumor histology | |
Adenocarcinoma | 25 (78%) |
Squamous cell | 7 (22%) |
Tumor grade | |
G1 | 1 (3%) |
G2 | 14 (44%) |
G3 | 17 (53%) |
cT category | |
cT1 | 1 (3%) |
cT2 | 3 (9%) |
cT3 | 27 (85%) |
Unknown | 1 (3%) |
eN category | |
cNO | 11 (34%) |
cN1 | 13 (41%) |
cN2 | 6 (19%) |
cN3 | 1 (3%) |
Unknown | 1 (3%) |
eM category | |
cMO | 32 (100%) |
cM1 | 0 (0%) |
cTNM stage | |
lb | 1 (3%) |
lc | 1 (3%) |
IIa | 4 (12%) |
lib | 6 (19%) |
lila | 14 (44%) |
lllb | 5 (16%) |
Unknown | 1 (3%) |
RT modality | |
Proton | 9 (28%) |
IMRT | 18 (57%) |
30 | 1 (3%) |
VMAT | 4 (12%) |
Surgery | 17 (53%) |
Induction chemo | 10 (31%) |